common challenges glp-1 users Are you currently taking a GLP-1? Many people navigate treatments with limited insight into how their bodies might respond. ๐คทโโ๏ธ Published this week, 23andMe scientists identified two genetic variants in the GLP-1 Agonist: The Good, the
Description
Do not discontinue tirzepatide without medical guidance if you experience sexual health concerns, as the benefits of improved metabolic health and weight management typically outweigh temporary or manageable side effects
Lifestyle strategies to help you maintain your results long after the 90 days are over
As competition and patient demand grow, broader coverage and more inclusive access policies are expected to follow
BMJ (2017) 359:j4849
Predicting the risk of weight loss after esophageal cancer surgery
A local weight loss clinic in Tempe should be transparent about the potential benefits and risks associated with Glucagon-Like Peptides (GLPs)
